 RARITAN, N.J., April 13, 2021 PRNewswire -- Ortho Clinical Diagnostics Nasdaq: OCDX, one of the worlds largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS SARS-CoV-2 Antigen Test, initially launched in October 2020. 